2010 Russian-American Pharmaceutical Conference

On behalf of the Pharmaceutical Research and Manufacturers of America and the Mid-Atlantic Russian Business Council, it is our great pleasure to invite you to the 2010 Russian-American Pharmaceutical Conference in Philadelphia, PA. This event will take place on April 27, 2010 in the Philadelphia City Hall, a splendid venue. This event will start off the 12th Semi-Annual Russian-American Innovation Technology Week with many activities devoted to innovation.

Despite many political changes over the years, Russia and the U.S have always been able to speak the language of science and progress in research to help develop technologies that benefit patients around the world. In the current environment, partnership is more important than ever. Whether between small and large companies, academia and industry, or the public and the private sectors, partnerships are now the key to success. This one-day conference will explore the opportunities to build mutually-supportive partnerships between the U.S. and Russia in the sphere of innovative pharmaceutical development.

With the adoption of the Pharma 2020 strategy, Russia has indicated its desire to be a world-class innovative bio-pharmaceutical producer and exporter. U.S. industry welcomes that goal and looks forward to a robust discussion about the policies that will achieve that goal. To that end, panels at this conference will acquaint participants with the Russian market overall and introduce key senior government officials responsible for policy. The conference will continue with in-depth discussion of the investment climate and key policy issues for Russia and the U.S.

The conference will also include a panel with representatives from the Health and the Business Development Working-Groups of the US-Russia Bilateral Presidential Commission. The panel will provide an update on the status of ongoing activities in the Working Groups, including plans for enhancing collaboration between the United States and Russia in the areas of public health and biomedical research, and a discussion of policy priorities in these areas.

The path forward for Russia and the U.S. is to exchange information and build long-term relationships in innovative sectors. We hope that this conference will further innovation in the life sciences and help find policy solutions that enable even stronger partnerships in the future. We are very grateful for the support of COMCON-Pharma as a key partner; Abbott, Amgen, Dechert and Baker & McKenzie as sponsors; as well as the support of conference partners, including the City of Philadelphia, State of Pennsylvania, State of New Jersey, U.S. Chamber of Commerce, Philadelphia U.S. Export Assistance Center of the U.S. Commercial Service, World Trade Center Delaware, Pennsylvania Bio, Bio New Jersey, Select Greater Philadelphia, Philadelphia Convention & Visitors Bureau, American Chamber of Commerce in Russia, Chamber of Commerce and Industry of the Russian Federation, Moscow Entrepreneurs Association and International Center for Technology Cooperation. We hope you will attend the first Russian-American Pharmaceutical Conference in April and look forward to meeting you.

With best regards,

For further information please contact Val Kogan, MARBC by phone at: (215) 708-2628, mobile: (484) 467-7444, via e-mail at: val@ma-rbc.org; or James Class, PhRMA by phone at (202) 835-3467, via email jclass@phrma.org.

To register, please click on the button below: